Latest Manufacturing News

Peak Processing delivered its first positive Group EBITDA quarter in FY2026, but the turnaround remains financially fragile. The ASX-listed THC beverage manufacturer reported a $7.8 million statutory loss, negative operating cash flow and an explicit material uncertainty over its ability to continue as a going concern.

Pure Foods Tasmania has warned of a material uncertainty over its ability to continue as a going concern after reporting an $8.6 million FY2026 loss, negative cash and a breach of its Commonwealth Bank covenant. The company expects its existing funding facilities to fall short from approximately February 2027, with further equity funding still uncommitted.

Radiopharm Theranostics reported a A$56.3 million comprehensive loss for fiscal 2026, with operating cash outflows rising to A$52.8 million and cash falling to A$4.1 million. The company says further funding is required, while auditors flag a material uncertainty over its ability to continue as a going concern.

Merino & Co cut its FY2026 loss by 20% as China revenue more than doubled, but group revenue declined and cash reserves fell sharply. The auditor highlighted a material uncertainty over the company’s ability to continue as a going concern.

Clarity Pharmaceuticals is approaching pivotal Phase III readouts for its prostate cancer imaging agent, backed by AUD178.3 million in liquid assets. The radiopharmaceutical developer remains deeply loss-making, but expanded manufacturing capacity and early clinical signals are pulling its commercial ambitions into sharper focus.

Rectifier Technologies has warned of a material uncertainty over its ability to continue as a going concern after revenue fell 41% and its annual loss widened to $6.39 million. An auditor-highlighted liquidity risk now sits alongside a $13 million order book and new EV charging products under development.

Canyon Resources has advanced construction at its Minim Martap bauxite project, but a lender’s drawdown suspension has delayed first shipment and created material uncertainty over the company’s ability to continue as a going concern. The annual report also details a recommended rejection of A2MP’s A$0.05-a-share takeover offer.

Energy Technologies has reported a deeper FY2026 loss, collapsing revenue and a $22.65 million equity deficiency, with its auditor flagging material uncertainty over the group’s ability to continue as a going concern. A five-year laser optics licence offers a potential new revenue path, but it remains conditional on development and future commercial sales.

Iperion reported a lower loss for the year ended 31 March 2026, but its cash reserves and net assets fell sharply, leaving the NZX-listed materials company reliant on related-party funding and director support. Its Pathoglaze manufacturing operation is also being moved from Malaysia to Singapore while customer trials continue.

Compumedics Limited (ASX:CMP) returned to profit in FY26 as record revenue, stronger cash generation and a sharp rise in MEG and SaaS sales reshaped its earnings profile. The company enters FY27 with A$28.3 million of open orders, but lower gross margins and uneven US and European execution remain key tests.

Papyrus Australia has produced a second batch of TBS board samples, expanded pulp capacity in Adelaide and secured additional funding as it moves towards commercial supply. The progress comes with testing still incomplete and an estimated 4.87 months of funding available.

6K Additive has signed a 30-month Nickel 718 powder supply agreement with US advanced manufacturer ADDMAN, carrying a stated value of up to US$10.8 million. The deal also introduces a buy-back arrangement for used powder, linking new sales with recycled feedstock.